Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Neuroendocrine Tumors 2Small Cell Lung Carcinoma 1Pulmonary Neuroendocrine Tumor 1Pancreatic Cancer Metastatic 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Differentiated Thyroid Cancer 1Carcinoma, Non-Small-Cell Lung 1Appendiceal Neoplasms 1Advanced Biliary Tract Cancer 1

Interventions

Gemcitabine 2toripalimab 1surufatinib 1Paclitaxel 1Injections 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pancreatic Cancer Metastatic × surufatinib × Clear all
NCT05969171 2025-07-30

A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Fudan University

Phase 2 Recruiting
65 enrolled
Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡